Similarly, plasma from COVID-19–recovered vaccinees after their first mRNA vaccine showed robust inhibition of ACE2 binding to RBDs from both ancestral and pre-Omicron VoCs (P ≤ 0.01) (Figure 3B). Here, ACE2 is linked to COVID-19.